← Vaishnavi Kundel

Papers by Vaishnavi Kundel

Page 1 · newest first

1. Orforglipron for Obstructive Sleep ApneaJAMA · 2026
2. Predictive performance of the Framingham risk score in obstructive sleep apnea cohorts: insights from the SAVE, RICCADSA, and ISAACC trialsBMC Pulmonary Medicine · 2026
3. Prototyping OSA: A New Framework for Predicting Cardiovascular Outcomes and CPAP Benefit2026
4. Adaptive Servo-Ventilation in Central Sleep Apnea: A Real-World PerspectiveAnnals of the American Thoracic Society · 2026
5. Orforglipron for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity or overweight: Study design and baseline characteristics of ATTAIN-OSA, a phase 3 trialContemporary Clinical Trials Communications · 2026
6. Clinical and Imaging Abnormalities Associated With Inducible Ventricular Arrhythmias During Electrophysiologic Study in Patients With Cardiac Sarcoidosis and Mildly Impaired Left Ventricular FunctionJournal of the American Heart Association · 2026
7. Individualized treatment effects of CPAP on secondary cardiovascular outcomes in non-sleepy obstructive sleep apnea patientsCommunications Medicine · 2026
8. Soluble cytokine receptor levels in obstructive sleep apnea patients treated with continuous positive airway pressure therapyFuture Science OA · 2026
9. Heterogeneity of Vascular Inflammation in Obstructive Sleep Apnea: Effects of CPAP TherapyAnnals of the American Thoracic Society · 2026
10. A Pre-Trained Model Customization Framework for Accelerated PET/MR Segmentation of Abdominal Fat in Obstructive Sleep ApneaDiagnostics · 2025
11. Treatment Preferences For Comorbid Obesity and Obstructive Sleep Apnea (PRO-CON OSA) Survey: Patient and Provider Preferences for CPAP and/or Tirzepatide2025
12. Obstructive Sleep Apnea: An Evolving Therapeutic Landscape with an Emerging Role for Incretin-Based TherapiesAdvances in Therapy · 2025
13. Exploring the Relationship Between Sleep Apnea, Myocardial Infarct Size, and Coronary Collaterals in Acute Myocardial Infarction: A Multidisciplinary StudyNature and Science of Sleep · 2025
14. The Great Controversy of Obstructive Sleep Apnea Treatment for Cardiovascular Risk Benefit: Advancing the Science Through Expert Consensus: An Official American Thoracic Society Workshop ReportAnnals of the American Thoracic Society · 2024
15. Achieving Better Understanding of Obstructive Sleep Apnea Treatment Effects on Cardiovascular Disease Outcomes through Machine Learning Approaches: A Narrative ReviewJournal of Clinical Medicine · 2024
16. Heterogeneous Effects of Continuous Positive Airway Pressure in Non-Sleepy Obstructive Sleep Apnea on Cardiovascular Disease Outcomes: Post Hoc Machine Learning Analysis of the ISAACC Trial (ECSACT Study)Annals of the American Thoracic Society · 2024
17. Beyond continuous positive airway pressure for cardiovascular risk reduction in patients with obstructive sleep apneaSLEEP Advances · 2024
18. Advanced Proteomics and Cluster Analysis for Identifying Novel Obstructive Sleep Apnea Subtypes before and after Continuous Positive Airway Pressure TherapyAnnals of the American Thoracic Society · 2023
19. Sleep-Disordered Breathing and Cardiac Arrhythmias in Adults: Mechanistic Insights and Clinical Implications: A Scientific Statement From the American Heart AssociationCirculation · 2022
20. Characterizing sleep–wake patterns in mothers and children in an agrarian community: results from the Ghana Randomized Air Pollution and Health StudySLEEP · 2022
21. Measuring Visceral Adipose Tissue Metabolic Activity in Sleep Apnea Utilizing Hybrid 18F-FDG PET/MRI: A Pilot StudyNature and Science of Sleep · 2021